Clinical trials are shifting toward adaptive designs, where protocols can be modified based on interim data without compromising scientific validity. These designs help reduce time, cost, and patient exposure to ineffective treatments.

Technology is also transforming trial operations. AI is being used to optimize trial design, recruitment, and outcome prediction, while digital monitoring devices allow continuous data collection outside clinical sites, making trials more patient-centered.